vs

Side-by-side financial comparison of Tarsus Pharmaceuticals, Inc. (TARS) and TUCOWS INC (TCX). Click either name above to swap in a different company.

Tarsus Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($151.7M vs $98.7M, roughly 1.5× TUCOWS INC). Tarsus Pharmaceuticals, Inc. runs the higher net margin — -5.5% vs -22.3%, a 16.8% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 6.0%). Tarsus Pharmaceuticals, Inc. produced more free cash flow last quarter ($13.0M vs $-7.0M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 6.2%).

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

Tucows Inc. is an American–Canadian publicly traded Internet services and telecommunications company headquartered in Toronto, Ontario, Canada, and incorporated in Pennsylvania, United States. The company is composed of three independent businesses: Tucows Domains, Ting Internet, and Wavelo.

TARS vs TCX — Head-to-Head

Bigger by revenue
TARS
TARS
1.5× larger
TARS
$151.7M
$98.7M
TCX
Growing faster (revenue YoY)
TARS
TARS
+122.4% gap
TARS
128.4%
6.0%
TCX
Higher net margin
TARS
TARS
16.8% more per $
TARS
-5.5%
-22.3%
TCX
More free cash flow
TARS
TARS
$19.9M more FCF
TARS
$13.0M
$-7.0M
TCX
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
6.2%
TCX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TARS
TARS
TCX
TCX
Revenue
$151.7M
$98.7M
Net Profit
$-8.4M
$-22.0M
Gross Margin
24.5%
Operating Margin
-5.3%
-9.1%
Net Margin
-5.5%
-22.3%
Revenue YoY
128.4%
6.0%
Net Profit YoY
63.8%
48.1%
EPS (diluted)
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TARS
TARS
TCX
TCX
Q4 25
$151.7M
$98.7M
Q3 25
$118.7M
$98.6M
Q2 25
$102.7M
$98.5M
Q1 25
$78.3M
$94.6M
Q4 24
$66.4M
$93.1M
Q3 24
$48.1M
$92.3M
Q2 24
$40.8M
$89.4M
Q1 24
$27.6M
$87.5M
Net Profit
TARS
TARS
TCX
TCX
Q4 25
$-8.4M
$-22.0M
Q3 25
$-12.6M
$-23.0M
Q2 25
$-20.3M
$-15.6M
Q1 25
$-25.1M
$-15.1M
Q4 24
$-23.1M
$-42.5M
Q3 24
$-23.4M
$-22.3M
Q2 24
$-33.3M
$-18.6M
Q1 24
$-35.7M
$-26.5M
Gross Margin
TARS
TARS
TCX
TCX
Q4 25
24.5%
Q3 25
24.5%
Q2 25
22.5%
Q1 25
24.9%
Q4 24
23.3%
Q3 24
24.0%
Q2 24
23.3%
Q1 24
20.9%
Operating Margin
TARS
TARS
TCX
TCX
Q4 25
-5.3%
-9.1%
Q3 25
-12.2%
-9.7%
Q2 25
-21.6%
-2.9%
Q1 25
-33.5%
-2.1%
Q4 24
-36.8%
-32.1%
Q3 24
-52.3%
-10.9%
Q2 24
-81.6%
-9.6%
Q1 24
-136.5%
-18.9%
Net Margin
TARS
TARS
TCX
TCX
Q4 25
-5.5%
-22.3%
Q3 25
-10.6%
-23.4%
Q2 25
-19.8%
-15.9%
Q1 25
-32.1%
-16.0%
Q4 24
-34.8%
-45.6%
Q3 24
-48.7%
-24.2%
Q2 24
-81.6%
-20.8%
Q1 24
-129.4%
-30.3%
EPS (diluted)
TARS
TARS
TCX
TCX
Q4 25
$-0.17
Q3 25
$-0.30
Q2 25
$-0.48
Q1 25
$-0.64
Q4 24
$-0.57
Q3 24
$-0.61
Q2 24
$-0.88
Q1 24
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TARS
TARS
TCX
TCX
Cash + ST InvestmentsLiquidity on hand
$417.3M
$46.8M
Total DebtLower is stronger
$72.4M
$190.4M
Stockholders' EquityBook value
$343.4M
$-164.2M
Total Assets
$562.2M
$730.9M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TARS
TARS
TCX
TCX
Q4 25
$417.3M
$46.8M
Q3 25
$401.8M
$54.1M
Q2 25
$381.1M
$52.0M
Q1 25
$407.9M
$38.1M
Q4 24
$291.4M
$56.9M
Q3 24
$317.0M
$75.2M
Q2 24
$323.6M
$39.3M
Q1 24
$298.5M
$66.6M
Total Debt
TARS
TARS
TCX
TCX
Q4 25
$72.4M
$190.4M
Q3 25
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$71.8M
$195.4M
Q3 24
$71.7M
Q2 24
$71.6M
Q1 24
$29.9M
Stockholders' Equity
TARS
TARS
TCX
TCX
Q4 25
$343.4M
$-164.2M
Q3 25
$335.1M
$-144.1M
Q2 25
$332.6M
$-121.7M
Q1 25
$342.5M
$-108.3M
Q4 24
$224.5M
$-95.3M
Q3 24
$237.5M
$-53.1M
Q2 24
$252.2M
$-33.1M
Q1 24
$275.2M
$-15.9M
Total Assets
TARS
TARS
TCX
TCX
Q4 25
$562.2M
$730.9M
Q3 25
$534.6M
$735.5M
Q2 25
$495.0M
$742.2M
Q1 25
$500.8M
$741.9M
Q4 24
$377.0M
$758.8M
Q3 24
$376.3M
$799.0M
Q2 24
$376.8M
$758.2M
Q1 24
$349.3M
$780.3M
Debt / Equity
TARS
TARS
TCX
TCX
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TARS
TARS
TCX
TCX
Operating Cash FlowLast quarter
$19.3M
$-2.6M
Free Cash FlowOCF − Capex
$13.0M
$-7.0M
FCF MarginFCF / Revenue
8.6%
-7.1%
Capex IntensityCapex / Revenue
4.2%
4.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.3M
$-22.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TARS
TARS
TCX
TCX
Q4 25
$19.3M
$-2.6M
Q3 25
$18.3M
$1.5M
Q2 25
$-29.4M
$6.6M
Q1 25
$-20.7M
$-11.3M
Q4 24
$-22.2M
$-4.8M
Q3 24
$-8.7M
$-4.6M
Q2 24
$-14.4M
$-4.7M
Q1 24
$-37.8M
$-5.7M
Free Cash Flow
TARS
TARS
TCX
TCX
Q4 25
$13.0M
$-7.0M
Q3 25
$16.3M
$-2.3M
Q2 25
$-30.4M
$3.1M
Q1 25
$-21.2M
$-16.7M
Q4 24
$-22.3M
$-16.5M
Q3 24
$-8.9M
$-19.1M
Q2 24
$-15.4M
$-20.7M
Q1 24
$-38.0M
$-20.0M
FCF Margin
TARS
TARS
TCX
TCX
Q4 25
8.6%
-7.1%
Q3 25
13.8%
-2.4%
Q2 25
-29.6%
3.1%
Q1 25
-27.1%
-17.6%
Q4 24
-33.5%
-17.7%
Q3 24
-18.6%
-20.7%
Q2 24
-37.8%
-23.1%
Q1 24
-137.5%
-22.9%
Capex Intensity
TARS
TARS
TCX
TCX
Q4 25
4.2%
4.4%
Q3 25
1.6%
3.9%
Q2 25
1.0%
3.5%
Q1 25
0.8%
5.7%
Q4 24
0.1%
12.5%
Q3 24
0.6%
15.7%
Q2 24
2.5%
17.8%
Q1 24
0.6%
16.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TARS
TARS

Segment breakdown not available.

TCX
TCX

Wholesale$57.0M58%
Fiber Internet Services$16.5M17%
Wavelo$13.0M13%
Platform Services$11.7M12%

Related Comparisons